Susan Hasty, Publisher
Table of Contents . . . February 15th, 1999Non-Subscriber - Summaries Only
At-Risk Populations (HBV) - Docs Not Complying with CDC Recommendations
Pathogenesis (HCV) - Lymphoid Cells May Explain Extrahepatic Dissemination
Therapy (HCV) - IFN Impact on Liver Fibrosis Progression Examined
Therapy (HCV) - Oligonucleotides May Be Useful in Treating Hepatitis C
Cholangiocarcinoma - Increased TSP-1, Decreased VEGF May Underlie Limited Angiogenesis
Growth Factors - VEGF Stimulates Liver Regeneration
Animal Models (HBV) - Trimera Disease Model Developed for Hepatitis B
Childhood Immunization (Hepatitis A) - Study Finds Universal Vaccination to be Effective and Cost-Effective
Industry News (Acquisitions) - Marketing Rights Acquired for Hepatitis C Test
Industry News (Hepatitis C) - Combination Therapy Advances to Phase III Trials
Immunization Program - "Immunization in a First Nations Community During a Hepatitis A Outbreak."
Disease Management (Cancer/HBV) - "Chemotherapy and Bone Marrow Transplantation for Cancer Patients Who Are also Chronic Hepatitis B Carriers: A Review of the Problem."
Transmission (HCV) - "Heterosexual Transmission of Hepatitis C in Italy."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.